Tate & Lyle PLC Half Year Results Announcement

| Filed in:

We have made a strong start to the year. Read more about our half year performance in our FY17 Results Announcement.

02 November 2017



For the six months to 30 September 2017

Strong First Half Performance

Key Headlines

  • 13%2 increase in Group adjusted PBT with volume growth in both business divisions
  • £10m increase in Speciality Food Ingredients adjusted operating profit to £104m:

– 3% volume growth, return to growth in North America (+1%), good growth in other regions

– 4%2 profit growth after investments to grow business over longer term

  • £29m increase in Bulk Ingredients adjusted operating profit to £93m:

– 16%2 profit growth in core, driven by strong execution, good demand and firm margins

– £10m profit from Commodities (2016: loss of £3m)

  • 14% increase in sales from New Products3 to US$58m
  • £33m higher Group reported PBT with improved trading and currency benefit
  • Adjusted effective tax rate 23.5% (2016: 18.3%); rate for fiscal 2018 expected in upper end of 21-24% guided range
  • 6%2 increase in adjusted diluted earnings per share from continuing operations to 27.6p
  • Net debt at £371m, £81m lower than 31 March 2017 with stronger adjusted free cash flow
  • Interim dividend increased by 0.2p to 8.4p

Javed Ahmed, Chief Executive, said:

“We have made a strong start to the year, with good performance across the Group and higher adjusted diluted earnings per share.

Speciality Food Ingredients delivered broad-based volume growth in the core business, including North America despite market conditions in that region remaining challenging.  New Products once again delivered double digit sales growth as customers continue to seek innovative solutions to reduce sugar, calories and fat in food and drink.

Bulk Ingredients had another period of excellent performance, well ahead of a strong comparative period, with improved overall earnings resulting from disciplined commercial execution and margin expansion.

Turning to the outlook, we expect underlying adjusted profit before tax in constant currency for the full year to be modestly higher than we anticipated coming into the year driven by the strong first half performance.”


1  The results for the six months to 30 September 2017 have been adjusted to exclude exceptional items, net retirement benefit interest, amortisation of acquired intangible assets, the tax on those adjustments and tax items that themselves meet these definitions. A reconciliation of statutory and adjusted information is included in Note 2 to the Financial Information.

2  Percentage changes in constant currency

  3  New Products represent products in the first seven years after launch

For more information contact Tate & Lyle PLC:

Christopher Marsh, Group VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688


Andrew Lorenz, FTI Consulting (Media)

Tel: +44 (0) 20 3727 1323 or Mobile: +44 (0) 7775 641 807


Download the Results

About Tate & Lyle: 
Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants).  It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or Linkedin.